scispace - formally typeset
L

Larry K. Pickering

Researcher at Centers for Disease Control and Prevention

Publications -  262
Citations -  20405

Larry K. Pickering is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Diarrhea & Rotavirus. The author has an hindex of 70, co-authored 262 publications receiving 19691 citations. Previous affiliations of Larry K. Pickering include University of Texas System & Eastern Virginia Medical School.

Papers
More filters
Journal Article

General recommendations on immunization; recommendations of the Advisory Committee on Immunization Practices (ACIP)

TL;DR: This revision of the General Recommendations on Immunization updates the 1989 statement and changes in the immunization schedule for infants and children include recommendations that the third dose of oral polio vaccine be administered routinely at 6 months of age rather than at age 15 months.
Journal ArticleDOI

Rotavirus Infection in Infants as Protection against Subsequent Infections

TL;DR: In infants, natural rotavirus infection confers protection against subsequent infection, which increases with each new infection and reduces the severity of the diarrhea.
BookDOI

Infections of the Gastrointestinal Tract

TL;DR: In conclusion, prolonged and exclusive breastfeeding reduces the risk of ltc gastrointestinal (gi) tract infection worksheet basidiobolomycosis: an emerging fungal infection of the urinary tract infection michigan medicine gastrointestinal tract: bacterial infections bacterial infections of the digestive tract.
Journal ArticleDOI

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

TL;DR: The updated recommendations in this policy statement reflect new information regarding the seasonality of RSV circulation, palivizumab pharmacokinetics, the changing incidence of bronchiolitis hospitalizations, the effect of gestational age and other risk factors on RSV hospitalization rates, the mortality of children hospitalized with RSV infection, the effects of prophylaxis on wheezing, and palivZumab-resistant RSV isolates.